Skip to main content
. 2020 Jun 21;21(12):4408. doi: 10.3390/ijms21124408

Figure 3.

Figure 3

Cell viability of GBM22–TMZ in the (a) freshly prepared formulations and (b) formulations stored at 4 °C for two weeks. Control indicates the medium group, lipoD indicates cholesterol/DMPC, BP represents the BP drug formulated in DMSO, and CDD1 indicates 25% BP encapsulated in CD and packed into cholesterol/DMPC. *** represents p < 0.001, ** represents p < 0.01, and * represents p < 0.05.